SYRS - Syros Pharmaceuticals' (SYRS) CEO Nancy Simonian on Q3 2020 Results - Earnings Call Transcript
Syros Pharmaceuticals, Inc. (SYRS) Q3 2020 Earnings Conference Call November 05, 2020 6:00 AM ET Company Participants Naomi Aoki – Vice President of Corporate Communications and Investor Relations Nancy Simonian – Chief Executive Officer David Roth – Chief Medical Officer Joe Ferra – Chief Financial Officer Conference Call Participants Kenneth Atkins – Cowen Ted Tenthoff – Piper Sandler Roy Buchanan – JMP Securities Zegbeh Jallah – ROTH Capital Partners Matt Biegler – Oppenheimer Matthew Cross – Alliance Global Presentation Operator Good afternoon, and welcome to Syros Pharmaceuticals' Third Quarter 2020 Financial Results Conference Call. At this time all participants are in a listen-only mode. This call is being webcast live on the Investors and Media section of Syros' website at www.syros.com. Please be advised that today's call is being recorded. Following the formal remarks, we will open the call up for your questions. [Operator Instructions] At this time, I would
For further details see:
Syros Pharmaceuticals' (SYRS) CEO Nancy Simonian on Q3 2020 Results - Earnings Call Transcript